Table 4.

Risk Ratios for Initiating Statins Within 90 Days of a Coronary Heart Disease Event Associated With Category of Coronary Heart Disease Event Experienced Excluding Patients Who Filled Any Nonstatin Lipid‐Lowering Medications During Baseline

	Categories of CHD Event
	AMI, Primary Discharge Diagnosis (n=4119)	AMI, Secondary Discharge Diagnosis (n=1732)	PCI (n=1182)	CABG (n=552)
Statin initiation, %	60.8	31.1	65.4	69.0
Risk ratio (95% CI) for initiating statins
Unadjusted	1 (ref)	0.51 (0.47 to 0.56)	1.08 (1.00 to 1.17)	1.14 (1.02 to 1.27)
Model 1	1 (ref)	0.53 (0.49 to 0.58)	0.99 (0.91 to 1.07)	1.02 (0.91 to 1.13)
Model 2	1 (ref)	0.59 (0.53 to 0.65)	1.00 (0.91 to 1.11)	1.09 (0.96 to 1.25)

Model 1 is adjusted for age, race, sex, and calendar year and accounted for clustering by hospital. Model 2 is adjusted for age, race, sex, calendar year, socioeconomic status, comorbidities (history of hyperlipidemia, history of diabetes, history of stroke, history of renal disease, history of depression, Charlson comorbidity index, all‐cause hospitalization), skilled nursing facility stay, nursing home residence, most recent cardiologist care, number of medications, filled nonstatin lipid‐lowering medications, duration of hospitalization for the index CHD event, and hospitalization during the 90 days following discharge and accounted for clustering by hospital. AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; CHD, coronary heart disease; PCI, percutaneous coronary intervention.